Substituted imidazole derivates
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
Novartis Vaccines and Diagnostics, Inc.
C C C C C C C A C C A C C A C C C C C C C C
C07D C07D C07D C07D C07D C07D C07D A61P C07D C07D A61P C07D C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Megan C. Eric Mark Elizabeth Sharadha Kelly Kay Hong Tinya Paul A. Liana Marie Savithri David Kris Rama Kenneth W. Sabina Rustum S. Anu Xia Paul A. Nathan Vincent P. Ryan N. Weibo Elisa Annette
Phillips Martin Knapp Mieuli Subramanian Wayman Huh Yang Abrams Barsanti Lagnition Ramurthy Duhl Mendenhall Jain Bair Pecchi Boyce Sharma Yia Renhowe Brammeier Le Constantine Wang Jazan Walter